NCT04544839

Brief Summary

Edentulous patients commonly experience a deterioration in the quality of life; both in terms of oral and general health. Studies demonstrated that conventional dentures do not adequately restore masticatory function nor quality of life. In contrast, implant-supported overdentures are considered the standard of care for edentulous patients as they offer a more stable prosthesis that ultimately results in improved oral function and patient satisfaction. Precision attachments such as studs, magnets, telescopic crowns or a bars are commonly used for implant supported overdentures. Implant overdentures supported by stud attachments gained popularity for the rehabilitation of edentulous patients as they are self-aligning, offer dual retention and compensate for divergence between implants up to angles of 40 degrees. However, it has been documented that the stud attachment system (Locators) requires a high frequency of maintenance, particularly with regard to the replacement of the matrix. In order to overcome some of these limitations of existing attachment systems, a newer system was developed consisting of a matrix made of polyetheretherketone (PEEK) instead of a polymeric material. This system has an amorphous diamond like carbon-based abutment coating (ADLC) and it was claimed to be more resistant to wear. Clinically and in vitro, no comparative studies have been performed addressing wear and retention of the traditional stud attachment and the newer ADLC attachment. Thus, the aim of the present study is to clinically and in vitro evaluate the ADLC and study attachment system.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
19mo left

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Nov 2020Jan 2028

First Submitted

Initial submission to the registry

August 26, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 10, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

November 2, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
5.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Expected
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

2.1 years

First QC Date

August 26, 2020

Last Update Submit

June 23, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Patient reported outcome measure

    Mean VAS scores (visual analogue scale (0-100)) related to patient overall satisfaction for the ADLC and the LOC (Locator) attachment system provided by the patients

    After a functional period of 6 months

Secondary Outcomes (7)

  • Patient-Reported Outcome Measures (PROMs): VAS

    6 months, 1, 3, 5 years after the evaluation period of the second attachment systems

  • Patient-Reported Outcome Measures (PROMs): OHIP-14

    6 months, 1, 3, 5 years after the evaluation period of the second attachment systems

  • Patient-Reported Outcome Measures (PROMs): Costs

    6 months, 1, 3, 5 years after the evaluation period of the second attachment systems

  • Technical outcomes:

    6 months after the first and the second evaluation period, respectively

  • Clinical outcomes: PCR

    after a functional period of 6 months for each attachment system; and1, 3 and 5 years after the evaluation period of the second attachment systems

  • +2 more secondary outcomes

Study Arms (2)

ADLC attachment in first phase

EXPERIMENTAL

Each patient will receive 2 implants in the canine region. Three months later, each patient will be randomized and half of the patients will receive first the ADLC (test) device (first phase). In the second phase of the crossover trial (6 months after the start of the first phase), the attachments will be replaced. Patients previously allocated to the ADLC group will receive the LOC attachments.

Device: ADLC attachment system with PEEK inserts

LOC attachment in first phase

ACTIVE COMPARATOR

Each patient will receive 2 implants in the canine region. Three months later, each patient will be randomized and half of the patients will receive first the LOC (control) device (first phase). In the second phase of the crossover trial (6 months after the start of the first phase), the attachments will be replaced. Patients previously allocated to the LOC group will receive the ADLC attachments.

Device: ADLC attachment system with PEEK inserts

Interventions

Each patient will receive 2 implants in the canine region using a guided-surgery protocol and a pre-prepared surgical stent. A healing abutment of an adequate size will be placed on the implant for transmucosal healing. The flaps will be subsequently sutured around the healing abutments. Patients' existing prostheses will be adjusted. Suture removal will be performed one week post implant placement. Three months later, implant level impressions will be made using the open tray technique. Each patient will be then be randomized using eCRF (electronic Case Report Form) to either ADLC group or LOC group. A final cast of the patients will be obtained and the attachments will be installed using an in-direct technique by a calibrated prosthodontists.

Also known as: NOVALOC
ADLC attachment in first phaseLOC attachment in first phase

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fully edentulous patients encountering problems (functional, aesthetics) with existing dentures in the upper and lower jaw or patients seeking for implant-supported prostheses
  • Adequate bone in the anterior mandible for the placement of implants (Regular diameter implant with a minimal length of 10mm) in the canine region
  • Written informed consent
  • Ability to understand the procedure and to answer a questionnaire.

You may not qualify if:

  • Impaired cognitive function and/or manual dexterity
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Unable to attend follow-up examinations
  • Known or suspected non-compliance, drug or alcohol abuse
  • Presence of any uncontrolled systematic disease that could compromise implant surgery and implant long-term performance
  • History of radiotherapy in the head and neck region
  • Heavy smoker (\>10 cig. /day
  • Any potential allergies or hypersensitivity to chemical ingredients of material used
  • Bruxism
  • Presence of bone metabolic disorders (e.g. osteoporosis)
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M.A.Rangoonwala College of Dental Sciences & Research Center

Pune, 411001, India

Location

Study Officials

  • Mohit Kheur, Prof.

    M.A.Rangoonwala College of Dental Sciences & Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 26, 2020

First Posted

September 10, 2020

Study Start

November 2, 2020

Primary Completion

December 1, 2022

Study Completion (Estimated)

January 1, 2028

Last Updated

June 24, 2022

Record last verified: 2022-06

Locations